Year None202120202019201820172014 Apr 10, 2021 PMV Pharma Presents Late-Breaking Preclinical Data on Lead Product Candidate PC14586 at the American Association for Cancer Research Annual Meeting 2021 Apr 06, 2021 PMV Pharma Strengthens Board of Directors with Appointment of Dr. Charles Baum Mar 10, 2021 PMV Pharmaceuticals Announces Presentation of PC14586 Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2021 Mar 03, 2021 PMV Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Corporate Highlights Feb 23, 2021 PMV Pharmaceuticals Announces Participation at the Cowen 41st Annual Health Care Conference Feb 16, 2021 PMV Pharma Appoints p53 Pioneer Dr. Guillermina Lozano to Scientific Advisory Board
